secwatch.observer — SEC 8-K summary
======================================

Issuer:     Tempest Therapeutics, Inc. (TPST)
CIK:        0001544227
Form:       8-K
Filed at:   2024-12-31T23:59:59+00:00
Accession:  0001193125-24-287170
Event type: regulatory
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Tempest Therapeutics receives Nasdaq bid price deficiency notice; stock below $1.00
--------------------------------------------------------------------------------

- Received Nasdaq deficiency letter on Dec 27, 2024 for bid price below $1.00 for 30 consecutive business days.
- Has 180 calendar days (until June 25, 2025) to regain compliance by closing at $1.00+ for 10 consecutive days.
- Stockholders approved a reverse stock split (range 1:2 to 1:15) on Dec 3, 2024; Board may implement to cure deficiency.
- If not compliant by June 25, 2025, may qualify for an additional 180-day period if other listing standards are met.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1544227/000119312524287170/0001193125-24-287170-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1544227/000119312524287170/d848354d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-287170

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer